Cheng Hu

1.6k total citations
71 papers, 1.1k citations indexed

About

Cheng Hu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Cheng Hu has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Pulmonary and Respiratory Medicine and 20 papers in Cancer Research. Recurrent topics in Cheng Hu's work include Cancer-related molecular mechanisms research (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Ferroptosis and cancer prognosis (8 papers). Cheng Hu is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Ferroptosis and cancer prognosis (8 papers). Cheng Hu collaborates with scholars based in China, United States and Japan. Cheng Hu's co-authors include Jiaqi Zhang, Meijuan Chen, Mingming Jin, Xu Zhang, Gang Huang, Chunzi Shi, Rilei Jiang, Li Tian, Yue Wu and Jianguang Qiu and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Cheng Hu

68 papers receiving 1.1k citations

Peers

Cheng Hu
Pei Xiao China
Sung‐Jig Lim South Korea
Wun‐Jae Kim South Korea
Hye-Jin Jang South Korea
Eunah Shin South Korea
Cheng Hu
Citations per year, relative to Cheng Hu Cheng Hu (= 1×) peers Junhua Zheng

Countries citing papers authored by Cheng Hu

Since Specialization
Citations

This map shows the geographic impact of Cheng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Hu more than expected).

Fields of papers citing papers by Cheng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Hu. The network helps show where Cheng Hu may publish in the future.

Co-authorship network of co-authors of Cheng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Hu. A scholar is included among the top collaborators of Cheng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Hu. Cheng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Shulei, Fengying Wu, Ning Wang, et al.. (2025). MMAE-Based Peptide–Drug Conjugates Targeting GPC3 for Precision Chemoradiotherapy in Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 68(12). 12950–12968. 1 indexed citations
2.
Zhang, Chi, Cheng Hu, Bowen Tang, et al.. (2025). UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(9). 2331–2351.
3.
Hu, Cheng, Yan Shen, Rumeng Zhang, et al.. (2025). Inhibiting mPGES-2 impedes renal cyst growth in mice with polycystic kidney disease. Acta Pharmacologica Sinica. 47(3). 689–700.
4.
Zhou, Zehua, et al.. (2024). Ginsenoside Rg1 Suppresses Pyroptosis via the NF-κB/NLRP3/GSDMD Pathway to Alleviate Chronic Atrophic Gastritis In Vitro and In Vivo. Journal of Agricultural and Food Chemistry. 72(24). 13668–13683. 8 indexed citations
5.
Hu, Cheng, et al.. (2024). Main chemical constituents and mechanism of anti‐tumor action of Solanum nigrum L. Cancer Medicine. 13(16). e7314–e7314. 3 indexed citations
6.
Jia, Chenglin, et al.. (2023). Fisetin Ameliorates Diabetic Nephropathy‐Induced Podocyte Injury by Modulating Nrf2/HO‐1/GPX4 Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2023(1). 9331546–9331546. 7 indexed citations
7.
Hu, Cheng, et al.. (2023). Simultaneous determination of fatty acids and related N-Acylethanolamines in rat plasma, rat tissue, and human plasma using UPLC-MS/MS. Microchemical Journal. 196. 109633–109633. 1 indexed citations
8.
Zhuang, Xiaoyu, Jiaqi Zhang, Meng Li, et al.. (2023). Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. Frontiers in Endocrinology. 14. 1171397–1171397. 6 indexed citations
9.
Li, Qingsong, Cheng Hu, Shengfa Su, et al.. (2023). Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy. Frontiers in Oncology. 13. 974735–974735. 2 indexed citations
10.
Wang, Jiaojian, Meng Yang, Cheng Hu, et al.. (2023). Predictive value of total ischaemic time and T1 mapping after emergency percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Clinical Radiology. 78(10). e724–e731. 2 indexed citations
11.
Zhao, Shasha, Gang Wang, Shengfa Su, et al.. (2022). The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury. Journal of Inflammation Research. Volume 15. 6357–6371. 3 indexed citations
12.
Wang, Jin, Ling Gu, Shiping Zhang, et al.. (2022). Induction of Ferroptosis by Ophiopogonin-B Through Regulating the Gene Signature AURKA in NSCLC. Frontiers in Oncology. 12. 833814–833814. 18 indexed citations
13.
Wang, Yu, et al.. (2022). Evaluation of NOTCH family genes’ expression and prognostic value in prostate cancer. Translational Andrology and Urology. 11(5). 627–642. 9 indexed citations
14.
Hu, Cheng, et al.. (2022). Solasonine Inhibits Pancreatic Cancer Progression With Involvement of Ferroptosis Induction. Frontiers in Oncology. 12. 834729–834729. 49 indexed citations
15.
Zhang, Xuelin, et al.. (2021). Dahuang Danshen Decoction Inhibits Pancreatic Fibrosis by Regulating Oxidative Stress and Endoplasmic Reticulum Stress. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 11 indexed citations
16.
Hu, Cheng, et al.. (2021). A new support of human activity research: Characteristics, research status, and application prospects of Wi-Fi data. 地理科学进展. 40(11). 1970–1982. 1 indexed citations
17.
Zhang, Shiping, Qian Gao, Ling Gu, et al.. (2021). Ophiopogonin B inhibits migration and invasion in non-small cell lung cancer cells through enhancing the interaction between Axin and β-catenin. Journal of Cancer. 12(20). 6274–6284. 14 indexed citations
18.
Chen, Meijuan, Cheng Hu, Qian Gao, et al.. (2020). Study on metastasis inhibition of Kejinyan decoction on lung cancer by affecting tumor microenvironment. Cancer Cell International. 20(1). 451–451. 11 indexed citations
19.
Hu, Cheng, et al.. (2020). Dihydrokaempferol (DHK) ameliorates severe acute pancreatitis (SAP) via Keap1/Nrf2 pathway. Life Sciences. 261. 118340–118340. 39 indexed citations
20.
Li, Ke, Yunhua Mao, Lu Li, et al.. (2016). Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel. International Journal of Oncology. 49(4). 1679–1685. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026